Currently viewing: 10. Non-current assets classified as held for sale | Next: 11. Subsequent events
| Assets R'000 |
Liabilities directly associated R'000 |
||
|---|---|---|---|
| Non-core business | 191 797 | (73 661) | |
| Cell C shares held for sale | 1 437 095 | — | |
| 1 628 892 | (73 661) |
Non-core business
As part of Blu Label Group's ongoing restructuring efforts to streamline operations and focus on core business activities, the Group has made the strategic decision to dispose of its shareholding in a Non-Core business ("NCB"). This decision aligns with the Group's objective to enhance operational efficiency and concentrate resources on areas that are central to its long‑term growth strategy.
The decision to sell this investment reflects the Group's commitment to optimising its portfolio and reallocating capital to more strategic initiatives. The carrying amount of the investment in the NCB approximates its fair value less costs to sell.
The Group is actively engaged in discussions with potential purchasers and expects to complete the transaction within the next six months. The NCB has been reported as a disposal group held for sale in the Group's consolidated financial statements for the period ended 30 November 2025. The NCB forms part of the Africa Distribution segment.
Cell C shares held for sale
The 15.95% stake in Cell C that was sold to Sisonke, but which continues to be recognised as part of TPC's economic interest in Cell C (refer to note 6.2) has been classified as a non-current asset held for sale at 30 November 2025.
The Group has committed to an active and formal programme to effect the disposal (derecognition of the shares) and has initiated discussions with identified potential purchasers and prospective funders. Management expects the transaction to be completed within the next 12 months. The proposed restructure is expected to enable TPC to redeploy capital more efficiently and to align funding resources with the Group's broader strategic and operational priorities.
The carrying value of the shares at 30 November 2025 approximates their fair value less costs to sell.
The Cell C shares form part of the Africa Distribution segment.
